Daito Pharmaceutical Co., Ltd.JP:4577Balance sheet

Market cap
¥41B
P/E ratio
17.8x
2014/052015/052016/052017/052018/052019/052020/052021/052022/052023/052024/052025/05
Cash and cash equivalents -1,9191,3511,6171,7111,8193,0843,3734,3813,6072,7272,207
Accounts receivable, net-9,8658,8139,3898,8319,3959,0668,382----
Inventories-8361,3151,6922,9062,7803,4834,2494,8755,6267,8776,843
Total current assets-21,71722,08124,34625,05624,36130,85532,43037,90940,66341,46041,708
Property, plant and equipment, net-16,44117,44717,87818,65418,73219,40021,37223,11625,83731,97231,826
Marketable securities, non-current -3,3583,0882,8292,8772,7803,1442,8022,7522,9643,1882,091
Total non-current assets-20,58821,25921,36222,14022,38923,39525,30927,03029,88836,24736,296
Total assets -42,30543,34045,70847,19646,74954,25057,73964,93970,55277,70878,004
Accounts payable-4,1773,6443,5873,6214,0864,3304,3604,4934,4355,2624,681
Short-term debt-3,0504,1702,7501,400-------
Long-term debt, current -2,4722,1142,0551,9651,8521,5121,3621,1891,4292,0993,099
Total current liabilities-15,98615,06615,23513,68411,61815,05412,85914,06915,42818,50517,049
Long-term debt, non-current -3,4353,6713,6944,0193,0941,5812,0182,2473,3684,6696,569
Total non-current liabilities-4,4654,7144,6595,0173,7822,3272,9633,1964,1516,9378,887
Total liabilities -20,45119,78019,89418,70115,40017,38115,82217,26519,58025,44325,936
Common stock and paid-in capital -8,6228,6228,6228,6228,62210,62712,42813,94814,25814,25814,258
Retained earnings-11,13813,32915,61018,23921,30224,74328,33232,33835,00637,08737,179
Stockholders' equity16,62521,85523,56025,81428,49631,34936,86841,91747,67450,97152,26552,067